Wachtell, Davis Polk Steer Mallinckrodt’s $6.7 Billion Merger With Endo

Wachtell, Lipton, Rosen & Katz is steering Mallinckrodt Pharmaceuticals and Davis Polk & Wardwell is guiding Endo Inc. in their plans to merge, creating a $6.7 billion company.

Mallinckrodt manufactures branded drugs like Acthar Gel for autoimmune disorders, as well as a generic oxycodone pain treatment. Endo is best known for making painkiller Percocet, which accounts for about half of its revenue. Both firms filed for bankruptcy amid lawsuits over the recent opioid crisis.

Wachtell’s team was led by corporate partner Victor Goldfeld, who has guided Mallinckrodt in several other deals, including its $1.2 billion acquisition of Sucampo Pharmaceuticals, $1.3 ...